Molecular Cancer (Jul 2023)

TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2

  • Estelle Balducci,
  • Thomas Steimlé,
  • Charlotte Smith,
  • Patrick Villarese,
  • Mélanie Feroul,
  • Dominique Payet-Bornet,
  • Sophie Kaltenbach,
  • Lucile Couronné,
  • Ludovic Lhermitte,
  • Aurore Touzart,
  • Marie-Emilie Dourthe,
  • Mathieu Simonin,
  • André Baruchel,
  • Hervé Dombret,
  • Norbert Ifrah,
  • Nicolas Boissel,
  • Bertrand Nadel,
  • Elizabeth Macintyre,
  • Agata Cieslak,
  • Vahid Asnafi

DOI
https://doi.org/10.1186/s12943-023-01794-y
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 6

Abstract

Read online

Abstract The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically designed NGS-capture pipeline, we here demonstrated the reintegration of T-cell receptor excision circles (TRECs) in 20/1533 (1.3%) patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Remarkably, the reintegration of TREC recurrently targeted the tumor suppressor gene, ZFP36L2, in 17/20 samples. Thus, our data identified a new and hardly detectable mechanism of gene deregulation in lymphoid cancers providing new insights in human oncogenesis.

Keywords